Associated tags: Engineering, Health, Research, Cure, Medical device
Locations: PARK AVENUE, EUROPEAN UNION, EU, FRANCE, CALIFORNIA, MALIBU, NEW YORK, MA, NEW YORK CITY
Xchange,
Pharmacology,
Health,
Mentorship,
NYCEDC,
Health equity,
Research,
Female,
Doctor of Philosophy,
Faculty,
NIH,
Male,
Syneos Health,
MPH,
Pediatrics,
Drug development,
Economic development,
Cure,
Nursing Deerfield Management, a New York City-based healthcare investment firm, founded and supports the XSeed Award.
Key Points:
- Deerfield Management, a New York City-based healthcare investment firm, founded and supports the XSeed Award.
- The deadline for XSeed Award application submissions is May 31, 2024, and virtual finalist presentations will be June 28, 2024.
- "Deerfield is pleased to continue our collaboration on the transformational XSeed program, alongside the NYCEDC, Cure and the experts who comprise our enthusiastic XSeed Award Leadership Committee."
- "We look forward to welcoming the XSeed Award winners who, along with the Cure Xchange Challenge winners, are startups advancing health through collaboration and community building via Cure."
Retrieved on:
Thursday, February 22, 2024
Xchange,
DREAM,
Cornell University,
Doctor of Philosophy,
Chronic kidney disease,
X-Change,
Amazon Web Services,
Challenge,
AI,
Research,
Education,
MD,
MIT,
Social work,
Mentorship,
Weill Cornell Medicine,
MBA,
Food,
MIT Solve,
Federally Qualified Health Center,
Economic development,
Health,
Therapy,
JD,
MIT Media Lab,
Good,
Health equity,
Housing,
NVIDIA,
Medical device NEW YORK, Feb. 22, 2024 /PRNewswire/ -- Cure®, a healthcare innovation campus in New York City, today announced the five winning startup companies of its inaugural Cure Xchange Challenge: Health AI for Good. The winners will receive one-year residencies at Cure, unrestricted seed money, mentoring, in-kind resources and support services from Cure's partners, such as Amazon Web Services, ThermoFisher and NVIDIA.
Key Points:
- NEW YORK, Feb. 22, 2024 /PRNewswire/ -- Cure® , a healthcare innovation campus in New York City, today announced the five winning startup companies of its inaugural Cure Xchange Challenge: Health AI for Good .
- Oatmeal Health : AI-enabled cancer screening provider focused on delivering early-detection, health equity, and care coordination services for marginalized communities of Federally Qualified Health Centers (FQHCs) and Health Plans.
- The event will include presentations from each winner and convene health, life science, and public sector leaders for discussions on AI in health.
- The Cure Xchange Challenge: Health AI for Good is the inaugural challenge in a series that Cure is developing to foster and improve cross-disciplinary health innovation.
Retrieved on:
Thursday, December 14, 2023
Carbon,
Health,
Boxing,
MED,
Patient,
CURE,
Weight loss,
LED,
Fitness,
Stay Awhile,
Partnership,
VIP,
Hotel,
Tourism LOS ANGELES, Dec. 14, 2023 /PRNewswire/ -- Stay Awhile Villas , a leading name in the luxury vacation rental industry founded by Stuart Heller, announced today an exclusive partnership with CURE , a renowned wellness and healthcare provider led by Dr. Lisa Benya.
Key Points:
- LOS ANGELES, Dec. 14, 2023 /PRNewswire/ -- Stay Awhile Villas , a leading name in the luxury vacation rental industry founded by Stuart Heller, announced today an exclusive partnership with CURE , a renowned wellness and healthcare provider led by Dr. Lisa Benya.
- All Stay Awhile guests will now have complimentary access to CURE's exclusive private members-only clubhouse during their stay.
- As of today, guests with reservations at any Stay Awhile Villas property will have access to CURE with their reservation.
- The partnership between Stay Awhile Villas and CURE marks a significant milestone in the hospitality industry.
Retrieved on:
Tuesday, December 12, 2023
European Economic Area,
Gait,
Research,
Engineering,
Food,
Organization,
Tetraplegia,
Spasm,
Patient,
Heart,
FDA,
Wheelchair,
Movement,
Health,
Rehabilitation,
Therapy,
Neuroscience,
Multiple sclerosis,
Atalante,
Pain,
Walking,
SCI,
Deep vein thrombosis,
Pharmaceutical industry,
Medical device,
Stroke,
Cure NEW YORK, Dec. 12, 2023 /PRNewswire/ -- Wandercraft, developer of the world's first in market self-stabilizing exoskeleton designed to enable people with walking impairments to stand and walk again, announced today the opening of its U.S. headquarters at Cure®, a healthcare innovation campus in New York City. The Company now has headquarters both in the U.S. where its CEO Matthieu Masselin has relocated, and in France where it originated, after receiving clearance from the U.S. Food and Drug Administration in early 2023 for its lead product, the hands-free Atalante X™ exoskeleton, for use in stroke rehabilitation.
Key Points:
- ET on Wednesday, Dec. 13 at Cure, 345 Park Avenue South, New York City.
- The event will include demonstrations of its new Personal Exoskeleton that will offer new, revolutionary options to those of us in wheelchairs.
- Wandercraft is joining Cure's group of start-up and established companies that have collectively raised more than $760 million since 2021.
- The campus community offers residents opportunities to create synergies and collaborative partnerships with peer organizations that span medical technology, healthcare services, therapeutics, healthcare investment, academic research and non-profit initiatives.
Retrieved on:
Monday, September 18, 2023
President Clinton,
Partnership,
Benefit,
Public,
Policy,
Health equity,
Climate change,
Artificial intelligence,
Climate,
Growth,
CGI,
AI,
Health,
Disease,
Medical device NEW YORK, Sept. 18, 2023 /PRNewswire/ -- Cure®, a healthcare innovation campus in New York City, will partner with the Clinton Global Initiative (CGI) to collaboratively pursue endeavors that address global health issues of equity, artificial intelligence, climate and maternal health.
Key Points:
- "Cure's commitment, announced at CGI 2023, shows an incredible dedication to the wellbeing of future generations, and we are grateful to Cure for stepping up and taking action."
- Launched by President Clinton in 2005, CGI brings together established and emerging global leaders to create and implement solutions to the world's most pressing challenges.
- The CGI 2022 meeting produced more than 140 Commitments to Action to improve access to health care, advance sustainability, create employment opportunities, support refugee resettlement, and more.
- "Cure's commitment with CGI reflects our shared mission to create and implement solutions to the world's most pressing challenges.
Retrieved on:
Tuesday, September 12, 2023
Xchange,
Good,
Heart,
Mentorship,
X-Change,
EST,
Research,
MIT,
DSM-IV codes,
Kaiser Permanente,
FAQ,
Science,
Alzheimer's disease,
MIT Solve,
Access,
Artificial intelligence,
Health,
BARDA,
CMIO,
Medical device,
Management,
Cure NEW YORK, Sept. 12, 2023 /PRNewswire/ -- Cure, a healthcare innovation campus in New York City, has opened applications for its Cure Xchange Challenge, a bold initiative to incubate innovations by healthcare start-ups and entrepreneurs across disciplines and sectors to responsibly and equitably use artificial intelligence (AI) in health. Applicants may submit projects designed to accelerate basic research, diagnose conditions, develop novel treatments, predict and prevent disease, or lead to better health outcomes and cures.
Key Points:
- Winners will have mentors from among Cure's executive advisory board and connections with world leaders, renowned entrepreneurs, public health experts and executives.
- "We are excited to be launching this challenge and looking forward to welcoming the winning teams to Cure.
- Applications for the Cure Xchange Challenge: Health AI for Good are open to U.S.-based applicants who are able to participate in a one-year New York City residency starting in February 2023.
- Applications are open to early-stage individuals or teams working at the concept, prototype or pilot stage of their AI solutions.
Retrieved on:
Friday, September 8, 2023
NEW YORK, Sept. 7, 2023 /PRNewswire/ -- Cure®, a healthcare innovation campus in New York City, will open and host key events of the Science Summit at the 78th United Nations General Assembly (UNGA78) taking place September 12 to 29, 2023. The Summit, with speakers from 116 countries, will focus on developing and launching new science collaborations to help attain the United Nations Sustainable Development Goals (SDGs).
Key Points:
- Sustainable Development Goals explored in 300+ sessions Sept. 12 to 29, 2023
Seema Kumar, Cure CEO, opens U.S. Science Summit with plenary on digital science, as special sessions address pandemic preparedness, genomics and more
NEW YORK, Sept. 7, 2023 /PRNewswire/ -- Cure® , a healthcare innovation campus in New York City, will open and host key events of the Science Summit at the 78th United Nations General Assembly (UNGA78) taking place September 12 to 29, 2023.
- The Summit, with speakers from 116 countries, will focus on developing and launching new science collaborations to help attain the United Nations Sustainable Development Goals (SDGs).
- "Cure's forward-thinking role in advancing science and technology is helping realize solutions with global potential, which will enhance our Summit discussions."
- Achieving this goal will require global collaboration in science, technology, and innovation at the intersection of disciplines, sectors and geographies.
CME,
University,
UCSD,
University of California, San Diego Performance-Based Skills Assessment,
Research,
Hematology,
Ultrasound research interface,
POCUS,
Patient,
Internal medicine,
Education,
Medical imaging,
Nursing For the first time, health care providers outside of UCSD, are invited to attend the UCSD Training on November 6-7 or December 6-7, 2023.
Key Points:
- For the first time, health care providers outside of UCSD, are invited to attend the UCSD Training on November 6-7 or December 6-7, 2023.
- The "Nussbaumer Method," developed by Karen Nussbaumer, has elevated ultrasound training, allowing practitioners to learn full-body ultrasound in just two days, even without prior ultrasound experience.
- Dr. Annette Von Drygalski, inspired by Karen's expertise, named the method after her participation in the vascular mastery ultrasound training.
- Join us at UCSD for this comprehensive two-day training, where we will shape the future of medical diagnosis through the "The New Physical Exam with Ultrasound" initiative.
Radiation,
Anatomy,
Curriculum,
Martha Nussbaum,
Cancer,
Diagnosis,
Research,
Ultrasound research interface,
Harvard Medical School,
Medical tourism,
Patient,
Vertically transmitted infection,
Knowledge,
Growth,
Family,
Education,
Medical device,
Medical imaging This program acknowledges individuals who have made significant contributions to healthcare and equips them with the necessary knowledge and skills to address complex challenges in global healthcare.
Key Points:
- This program acknowledges individuals who have made significant contributions to healthcare and equips them with the necessary knowledge and skills to address complex challenges in global healthcare.
- Reflecting on her experience, Nussbaumer expressed profound appreciation for the program, emphasizing its significant impact on her.
- A highlight for her was meeting her fellow classmates, dedicated global healthcare leaders committed to a shared mission of healing the harms of healthcare.
- Furthermore, Nussbaumer has been at the forefront of initiatives to reduce medical radiation in global healthcare.
BIO,
BCH,
Road,
Super Session,
Exhibition,
MB,
Disease,
Biotechnology,
Huntington Avenue,
Brigham and Women's Hospital,
Health,
Boston Convention and Exhibition Center,
Research,
Doctor of Philosophy,
Michigan Biotechnology Institute,
EDT,
Harvard Medical School,
BCEC,
BAO,
Pandemic,
MD,
JD,
ABC,
Coffee,
Convention center,
Neurology,
ESG,
Digital,
Foreign policy,
Ecosystem,
AI,
Alzheimer's disease,
Hospital,
Woman,
WIB,
Pharmaceutical industry,
Organon,
Cure NEW YORK, June 2, 2023 /PRNewswire/ -- Cure®, a healthcare innovation campus in New York City, today announced a one-of-a-kind Super Session featuring experts focused on leveraging AI for good as part of the company's presence at the Biotechnology International Convention, the largest global event for the biotech industry, in Boston, MA. from June 5 to 8, 2023.
Key Points:
- "The dizzying array of things AI can seemingly do – good, great, and worrisome – has the world of healthcare both excited and overwhelmed.
- For the BIO Super Session, the panel Cure has gathered will discuss how we can optimally leverage AI and other advanced technologies while mitigating risks," said Cure Chief Executive Officer Seema Kumar.
- The Cure booth also will host Cure Studios on the Road, capturing highlights and insights from leading biotech executives.
- The booth will be open 8:00 am to 5:00 pm EDT in the BCEC Ground Level Halls A-C from June 5 to 8, 2023.
